Cargando…
What is the Best Treatment for a Cancer Patient with Thrombosis?
The relationship between venous thromboembolism and cancer has been known for many years, and there is solid scientific evidence addressing the adequate treatment of this condition in oncology patients. However, established prescribing habits, individual patient challenges, and uncertainty concernin...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011719/ https://www.ncbi.nlm.nih.gov/pubmed/24855404 http://dx.doi.org/10.4137/CMO.S13386 |
_version_ | 1782314829435895808 |
---|---|
author | Barbosa, Miguel |
author_facet | Barbosa, Miguel |
author_sort | Barbosa, Miguel |
collection | PubMed |
description | The relationship between venous thromboembolism and cancer has been known for many years, and there is solid scientific evidence addressing the adequate treatment of this condition in oncology patients. However, established prescribing habits, individual patient challenges, and uncertainty concerning treatment justifies poor adherence to published guidelines. This paper reviews venous thromboembolism treatment while focusing on vitamin K antagonists, low-molecular-weight heparins, and novel oral anticoagulants, namely in terms of their efficacy and limitations. |
format | Online Article Text |
id | pubmed-4011719 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Libertas Academica |
record_format | MEDLINE/PubMed |
spelling | pubmed-40117192014-05-22 What is the Best Treatment for a Cancer Patient with Thrombosis? Barbosa, Miguel Clin Med Insights Oncol Review The relationship between venous thromboembolism and cancer has been known for many years, and there is solid scientific evidence addressing the adequate treatment of this condition in oncology patients. However, established prescribing habits, individual patient challenges, and uncertainty concerning treatment justifies poor adherence to published guidelines. This paper reviews venous thromboembolism treatment while focusing on vitamin K antagonists, low-molecular-weight heparins, and novel oral anticoagulants, namely in terms of their efficacy and limitations. Libertas Academica 2014-05-01 /pmc/articles/PMC4011719/ /pubmed/24855404 http://dx.doi.org/10.4137/CMO.S13386 Text en © 2014 the author(s), publisher and licensee Libertas Academica Ltd. This is an open-access article distributed under the terms of the Creative Commons CC-BY-NC 3.0 License. |
spellingShingle | Review Barbosa, Miguel What is the Best Treatment for a Cancer Patient with Thrombosis? |
title | What is the Best Treatment for a Cancer Patient with Thrombosis? |
title_full | What is the Best Treatment for a Cancer Patient with Thrombosis? |
title_fullStr | What is the Best Treatment for a Cancer Patient with Thrombosis? |
title_full_unstemmed | What is the Best Treatment for a Cancer Patient with Thrombosis? |
title_short | What is the Best Treatment for a Cancer Patient with Thrombosis? |
title_sort | what is the best treatment for a cancer patient with thrombosis? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011719/ https://www.ncbi.nlm.nih.gov/pubmed/24855404 http://dx.doi.org/10.4137/CMO.S13386 |
work_keys_str_mv | AT barbosamiguel whatisthebesttreatmentforacancerpatientwiththrombosis |